Princeton, N.J.- and Paris-based Stentys focuses on stents, such as its CE Mark-approved self-apposing stent, which utilizes Stentys’ self-expanding technology to better position the stent. The company now has unnamed distributors for its product line in Singapore, Hong Kong and Malaysia, according to a press release.
"Stentys’ sales expansion through national distributors in the Middle East was a substantial success in 2013, and we plan to replicate this model across Asia. The excellent feedback we have received from opinion leaders in this new region makes us confident that our stent will be rapidly adopted in Southeast Asia," Co-founder and CEO Gonzague Issenmann said in prepared remarks.
Stentys spent 2013 reaching for new markets, expanding into the Middle East with strong results. Stentys attributed better-than-expected 2nd quarter revenue to gaining ground in Europe and Middle-Eastern markets, where physicians are more routinely choosing the company’s self-apposing stents. The company has yet to land FDA approval.